blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2044935

EP2044935 - A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.11.2011
Database last updated on 06.07.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU
published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Vivacell Biotechnology Espana S.L.
Avda. Conde de Vallellano, 13, 1-1
14004 Cordoba / ES
[2009/15]
Inventor(s)01 / Muñoz Blanco, Eduardo
VIVACELL BIOTECHNOLOGY ESPAÑA, S.L. Avda. Conde de Vallellano, 13, 1-1
14004, Córdoba / ES
02 / Appendino, Giovanni
VIVACELL BIOTECHNOLOGY ESPAÑA, S.L. Avda. Conde de Vallellano, 13, 1-1
14004, Córdoba / ES
03 / Fiebich, Bernd L.
VIVACELL BIOTECHNOLOGY ESPAÑA, S.L. Avda. Conde de Vallellano, 13, 1-1
14004, Córdoba / ES
04 / Grassi, Giampaolo
VIVACELL BIOTECHNOLOGY ESPAÑA, S.L. Avda. Conde de Vallellano, 13, 1-1
14004, Córdoba / ES
 [2009/15]
Representative(s)Illescas, Manuel
GONZÁLEZ-BUENO & ILLESCAS
Calle de Recoletos, 13 - 5 lzq.
28001 Madrid / ES
[N/P]
Former [2010/21]Illescas, Manuel
GONZÁLEZ-BUENO & ILLESCAS Calle de Recoletos, 13 - 5 lzq.
28001 Madrid / ES
Former [2009/15]Pons Arino, Angel
Pons Patentes y Marcas Internacional, S.L. Glorieta Ruben Dario 4
28010 Madrid / ES
Application number, filing date07117778.602.10.2007
[2009/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2044935
Date:08.04.2009
Language:EN
[2009/15]
Type: B1 Patent specification 
No.:EP2044935
Date:05.01.2011
Language:EN
[2011/01]
Search report(s)(Supplementary) European search report - dispatched on:EP27.02.2008
ClassificationIPC:A61K31/05, A61K31/352, A61K36/185, A61P29/00, A61P35/00
[2009/15]
CPC:
A61K36/185 (EP,US); A61K31/05 (EP,US); A61K31/352 (EP,US);
A61P1/04 (EP); A61P29/00 (EP); A61P35/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/15]
TitleGerman:Zusammensetzung mit nicht-psychotropen Cannabinoiden zur Behandlung von Entzündungserkrankungen[2009/15]
English:A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases[2009/15]
French:Composition contenant des cannabinoïdes non psychotropes pour le traitement de maladies inflammatoires[2009/15]
Examination procedure14.05.2008Amendment by applicant (claims and/or description)
14.05.2008Examination requested  [2009/15]
03.07.2008Despatch of a communication from the examining division (Time limit: M04)
13.10.2008Reply to a communication from the examining division
23.06.2009Despatch of a communication from the examining division (Time limit: M04)
23.10.2009Reply to a communication from the examining division
02.12.2009Despatch of a communication from the examining division (Time limit: M04)
11.03.2010Reply to a communication from the examining division
22.04.2010Communication of intention to grant the patent
06.05.2010Observations by third parties
03.08.2010Fee for grant paid
03.08.2010Fee for publishing/printing paid
Opposition(s)06.10.2011No opposition filed within time limit [2011/50]
Fees paidRenewal fee
02.11.2009Renewal fee patent year 03
02.11.2010Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT05.01.2011
BE05.01.2011
CY05.01.2011
CZ05.01.2011
DK05.01.2011
EE05.01.2011
FI05.01.2011
HU05.01.2011
LT05.01.2011
LV05.01.2011
MT05.01.2011
PL05.01.2011
RO05.01.2011
SE05.01.2011
SI05.01.2011
SK05.01.2011
TR05.01.2011
BG05.04.2011
GR06.04.2011
IS05.05.2011
PT05.05.2011
IE02.10.2011
LU02.10.2011
[2013/45]
Former [2013/44]AT05.01.2011
BE05.01.2011
CY05.01.2011
CZ05.01.2011
DK05.01.2011
EE05.01.2011
FI05.01.2011
LT05.01.2011
LV05.01.2011
MT05.01.2011
PL05.01.2011
RO05.01.2011
SE05.01.2011
SI05.01.2011
SK05.01.2011
TR05.01.2011
BG05.04.2011
GR06.04.2011
IS05.05.2011
PT05.05.2011
IE02.10.2011
LU02.10.2011
Former [2013/25]AT05.01.2011
BE05.01.2011
CY05.01.2011
CZ05.01.2011
DK05.01.2011
EE05.01.2011
FI05.01.2011
LT05.01.2011
LV05.01.2011
MT05.01.2011
PL05.01.2011
RO05.01.2011
SE05.01.2011
SI05.01.2011
SK05.01.2011
BG05.04.2011
GR06.04.2011
IS05.05.2011
PT05.05.2011
IE02.10.2011
LU02.10.2011
Former [2013/14]AT05.01.2011
BE05.01.2011
CY05.01.2011
CZ05.01.2011
DK05.01.2011
EE05.01.2011
FI05.01.2011
LT05.01.2011
LV05.01.2011
MT05.01.2011
PL05.01.2011
RO05.01.2011
SE05.01.2011
SI05.01.2011
SK05.01.2011
BG05.04.2011
GR06.04.2011
IS05.05.2011
PT05.05.2011
IE02.10.2011
Former [2012/47]AT05.01.2011
BE05.01.2011
CY05.01.2011
CZ05.01.2011
DK05.01.2011
EE05.01.2011
FI05.01.2011
LT05.01.2011
LV05.01.2011
PL05.01.2011
RO05.01.2011
SE05.01.2011
SI05.01.2011
SK05.01.2011
BG05.04.2011
GR06.04.2011
IS05.05.2011
PT05.05.2011
IE02.10.2011
Former [2011/50]AT05.01.2011
BE05.01.2011
CY05.01.2011
CZ05.01.2011
DK05.01.2011
EE05.01.2011
FI05.01.2011
LT05.01.2011
LV05.01.2011
PL05.01.2011
RO05.01.2011
SE05.01.2011
SI05.01.2011
SK05.01.2011
BG05.04.2011
GR06.04.2011
IS05.05.2011
PT05.05.2011
Former [2011/47]AT05.01.2011
BE05.01.2011
CY05.01.2011
DK05.01.2011
EE05.01.2011
FI05.01.2011
LT05.01.2011
LV05.01.2011
PL05.01.2011
SE05.01.2011
SI05.01.2011
BG05.04.2011
GR06.04.2011
IS05.05.2011
PT05.05.2011
Former [2011/38]AT05.01.2011
BE05.01.2011
CY05.01.2011
FI05.01.2011
LT05.01.2011
LV05.01.2011
PL05.01.2011
SE05.01.2011
SI05.01.2011
BG05.04.2011
GR06.04.2011
IS05.05.2011
PT05.05.2011
Former [2011/37]BE05.01.2011
CY05.01.2011
FI05.01.2011
LT05.01.2011
LV05.01.2011
PL05.01.2011
SE05.01.2011
SI05.01.2011
BG05.04.2011
GR06.04.2011
IS05.05.2011
PT05.05.2011
Former [2011/36]LT05.01.2011
LV05.01.2011
PL05.01.2011
SE05.01.2011
SI05.01.2011
GR06.04.2011
IS05.05.2011
PT05.05.2011
Former [2011/33]LT05.01.2011
SI05.01.2011
Documents cited:Search[Y]WO9952524  (MATHILDA & TERENCE KENNEDY INS [GB], et al) [Y] 1-13 * whole document;; claims 1-3,5-8 * * page 5, lines 5-10 *;
 [XY]US6403126  (WEBSTER G R BARRIE [CA], et al) [X] 2,11-13 * column 2, lines 5-19,37-39 * * column 3, line 61 - column 4, line 1 * * column 4, lines 4-22 * * column 5, lines 2-12 * * column 6, lines 23-29 * * claims 1,8 * [Y] 1-13;
 [DX]  - 7 REUNION ANUAL, SOCIEDAD ESPAÑOLA DE INVESTIGACION SOBRE CANNABINOIDES, TOLEDO, 23-25 NOVIEMBRE 2006, (200611), pages 1 - 44, URL: http://www.ucm.es/info/seic-web/libro2006.pdf, (20080130), XP002469010 [DX] 1,3-12 * page 33 * * page 34 *
 [Y]  - EVANS A T ET AL, "CONSTITUENTS OF CANNABIS-SATIVA INHIBIT LIPOXYGENASE ACTIVITY", JOURNAL OF PHARMACY AND PHARMACOLOGY, LONDON, GB, (19850909), vol. 37, ISSN 0022-3573, page 43P, XP002114256 [Y] 1-13 * whole document *
 [Y]  - BARRETT ML ET AL, "Cannflavin A and B, prenylated flavones from Cannabis sativa L", EXPERIENTIA, BIRKHAEUSER VERLAG. BASEL, CH, (19860415), vol. 42, no. 4, ISSN 0014-4754, pages 452 - 453, XP002114248 [Y] 1-13 * abstract *

DOI:   http://dx.doi.org/10.1007/BF02118655
 [Y]  - ELSOHLY H ET AL, "CANNIPRENE A PROTOTYPE ANTI-INFLAMMATORY NATURAL PRODUCT", PLANTA MEDICA, THIEME, STUTTGART, DE, (1990), vol. 56, no. 6, ISSN 0032-0943, pages 662 - 663, XP009095318 [Y] 1-13 * whole document *

DOI:   http://dx.doi.org/10.1055/s-2006-961322
 [Y]  - BAEK S H ET AL, "BORON TRIFLUORIDE ETHERATE ON SILICA-A MODIFIED LEWIS ACID REAGENT (7). ANTITUMOR ACTIVITY OF CANNABIGEROL AGAINST HUMAN ORAL EPITHELOID CARCINOMA CELLS", ARCHIVES OF PHARMACAL RESEARCH, NATL. FISHERIES UNIVERSITY, PUSAN, KR, (199806), vol. 21, no. 3, ISSN 0253-6269, pages 353 - 356, XP000957635 [Y] 1-13 * abstract *
 [DY]  - YANG KUO-CHING ET AL, "Molecular mechanisms of denbinobin-induced anti-tumorigenesis effect in colon cancer cells.", WORLD JOURNAL OF GASTROENTEROLOGY : WJG 28 MAY 2005, (20050528), vol. 11, no. 20, ISSN 1007-9327, pages 3040 - 3045, XP002469127 [DY] 1-13 * abstract *
other   - "Majoon-e-Rawand Barae Dard-e-Meda", TKDL, Database accession no. MH5/1398, XP003024332
    - MOHAMMAD AKBAR ARZANI, Qaraabaadeen Qaadri, (1968), page 202
    - "Shahdanaj", TKDL, Database accession no. AH1/414, XP003024333
    - ABU ALI IBN-E-SINA, Al-Qaanoon-fil-Tibb, (1987), page 253
    - "Sarvangasothahara", TKDL, Database accession no. RS23/981B, XP003024334
    - VÄGABHATA, Astänga Hrdaya, (1998), page 705
    - "Kodaga Sala Kuligai", TKDL, Database accession no. GP04/82, XP003024335
    - THERAYAR, Therayar Maha Karisal, (1974), pages 84 - 87
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.